6190 Share Price Performance
JP¥0
-324.00 (-100.00%)
Price JP¥0
Share Pricen/a
Is PhoenixBio (TSE:6190) Using Too Much Debt?
Dec 01
PhoenixBio Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6190 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
PhoenixBio Co., Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 13, 2026
- -76.65
- 75.88%
- -20.68%
- 26.0%
About 6190
- Founded
- 2002
- Employees
- 69
- CEO
- WebsiteView website
PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
